"AVA MD, a Medical and Cosmetic Dermatology practice, was founded by Dr. Ava Shamban to provide a spirited, results-driven approach to skin care, supported by advanced technology and a rigorously trained staff committed to extraordinary service."

During the past decade, AVA MD conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AVA MD" #1 sponsor was "ATS Clinical Research" with 1 trials, followed by "Croma-Pharma GmbH" with 1 trials sponsored, "Galderma R&D" with 1 trials sponsored, "Kythera Biopharmaceuticals" with 1 trials sponsored and "Pulse Biosciences, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AVA MD" #1 collaborator was "Allergan" with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "AVA MD" are "Dermatological Non-Disease" (1 trials), "Glabellar Frown Lines (GL)" (1 trials), "Hypotrichosis" (1 trials), "Lateral Canthal Lines (LCL)" (1 trials) and "Moderate or Severe Submental Fullness" (1 trials). Many other conditions were trialed in "AVA MD" in a lesser frequency.

Most popular intervention types in "AVA MD" are "Device" (2 trials), "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Deoxycholic acid injection" (1 trials), "Nano-Pulse Stimulation (NPS)" (1 trials), "Placebo" (1 trials), "Princess Filler Lidocaine" (1 trials) and "Track A" (1 trials). Other intervention names were less common.

The vast majority of trials in "AVA MD" are 5 trials for "All" genders.

Currently, there are NaN active trials in "AVA MD". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in AVA MD, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in AVA MD, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".